SSY Group (HKG:2005) obtained registration approval from China's National Medical Products Administration for Piribedil to become a bulk drug for the preparations on the market, a Monday filing with the Hong Kong bourse said.
Piribedil is used mainly to treat Parkinson's disease and circulatory disturbance, according to the pharmaceutical company.